Literature DB >> 19455464

Bright CD38 expression is an indicator of MYC rearrangement.

Atousa Maleki, Adam C Seegmiller, Naseem Uddin, Nitin J Karandikar, Weina Chen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19455464     DOI： 10.1080/10428190902930470

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  3 in total

1.  A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.

Authors:  Grzegorz Rymkiewicz; Beata Grygalewicz; Magdalena Chechlinska; Katarzyna Blachnio; Zbigniew Bystydzienski; Joanna Romejko-Jarosinska; Renata Woroniecka; Michalina Zajdel; Katarzyna Domanska-Czyz; David Martin-Garcia; Ferran Nadeu; Pawel Swoboda; Jolanta Rygier; Barbara Pienkowska-Grela; Jan Konrad Siwicki; Monika Prochorec-Sobieszek; Itziar Salaverria; Reiner Siebert; Jan Walewski
Journal:  Mod Pathol       Date:  2018-01-12       Impact factor: 7.842

2.  Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RC.

Authors:  Lan V Pham; Gary Lu; Archito T Tamayo; Juan Chen; Pramoda Challagundla; Jeffrey L Jorgensen; L Jeffrey Medeiros; Richard J Ford
Journal:  J Hematol Oncol       Date:  2015-10-29       Impact factor: 17.388

3.  Generation and characteristics of a novel "double-hit" high grade B-cell lymphoma cell line DH-My6 with MYC/IGH and BCL6/IGH gene arrangements and potential molecular targeted therapies.

Authors:  Hiroaki Kikuchi; Tomonori Higuchi; Yumiko Hashida; Ayuko Taniguchi; Mikio Kamioka; Takahiro Taguchi; Akihito Yokoyama; Ichiro Murakami; Mikiya Fujieda; Masanori Daibata
Journal:  Oncotarget       Date:  2018-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.